Organic compounds

Details for Australian Patent Application No. 2004272285 (hide)

Owner Novartis AG

Inventors Damon, Robert Edson; Vedananda, Thalaththani Ralalage

Agent Davies Collison Cave

Pub. Number AU-B-2004272285

PCT Pub. Number WO2005/026134

Priority 60/503,950 17.09.03 US

Filing date 16 September 2004

Wipo publication date 24 March 2005

Acceptance publication date 27 November 2008

International Classifications

C07C 233/22 (2006.01) Carboxylic acid amides

C07C 311/21 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 311/29 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 311/46 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07D 263/32 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 277/56 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 317/60 (2006.01) Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/026134 Priority application(s): WO2005/026134

27 November 2008 Application Accepted

  Published as AU-B-2004272285

26 March 2009 Standard Patent Sealed

14 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004272288-2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders

2004272283-2,4 di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or Syk inhibitors